InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank71
3Y CAGR-12.4%
5Y CAGR+1.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-12.4%/yr
vs +21.0%/yr prior
5Y CAGR
+1.4%/yr
Recent deceleration
Acceleration
-33.4pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $9.62M | +4.2% |
| 2024 | $9.24M | -5.6% |
| 2023 | $9.78M | -31.8% |
| 2022 | $14.34M | +17.8% |
| 2021 | $12.17M | +35.7% |
| 2020 | $8.97M | -13.7% |
| 2019 | $10.39M | +55.5% |
| 2018 | $6.69M | +94.4% |
| 2017 | $3.44M | +87.2% |
| 2016 | $1.84M | - |